Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2012 | Mitralign | $35.0M Series D | Forbion | 4See Ventures, Giza Venture Capital, Johnson & Johnson Innovation, Medtronic, Oakwood Medical Investors, Oxford Bioscience Partners, Palisade Capital Management, Saints Capital, Triathlon Medical Ventures |